Pharmaceutical Research
Basic Information
Brief Name:
PHARM RES
Impact Factor:
3.5
ISSN:
0724-8741
Research Field:
MEDICAL
h-index:
191
Self-citation Rate:
2.9%
Articles per Year:
182
SCI Index Status:
Science Citation Index Expanded
Journal Website:
https://www.springer.com/11095
Journal Introduction:
Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, is committed to publishing novel research that is mechanism-based, hypothesis-driven and addresses significant issues in drug discovery, development and regulation. Current areas of interest include, but are not limited to: (pre)formulation engineering and processing computational biopharmaceutics drug delivery and targeting molecular biopharmaceutics and drug disposition (including cellular and molecular pharmacology) pharmacokinetics, pharmacodynamics and pharmacogenetics Research may involve nonclinical and clinical studies, and utilize both in vitro and in vivo approaches. Studies on small drug molecules, pharmaceutical solid materials (including biomaterials, polymers and nanoparticles) biotechnology products (including genes, peptides, proteins and vaccines), and genetically engineered cells are welcome.
CiteScore
CiteScore
6.6
SJR
0.707
SNIP
0.897
| Subject | Rank | Percentile |
|---|---|---|
MedicinePharmacology (medical) |
65 / 272 | 76% |
Journal Statistics
Monthly
Issues/Year
Submission to first decision (median): 6 days
Review Cycle
£2790/$4390/€3390
Article Processing Fee
Submission Information
Submission Website:
https://www.editorialmanager.com/pham/Recommended Journals
European Journal of Organic Chemistry
Faraday Discussions
Coloration Technology
Nature Reviews Drug Discovery
Mini-Reviews in Medicinal Chemistry
Current Pharmaceutical Biotechnology
Journal of Enzyme inhibition and Medicinal Chemistry
Green Chemistry
Physical Chemistry Chemical Physics
Contact Lens & Anterior Eye
Related Articles
Stability and spinodal decomposition of the solid-solution phase in the ruthenium–cerium–oxide electro-catalyst
Yanmei Li, Xin Wang, Yanqun Shao, Bo Wu, Zhongzhi Tang, Wei Lin
2014-10-29
Paper
DOI: 10.1039/C4CP04131C
Illuminating surface atoms in nanoclusters by differential X-ray absorption spectroscopy
Charles S. Spanjers, Thomas P. Senftle, Adri C. T. van Duin, Michael J. Janik, Anatoly I. Frenkel, Robert M. Rioux
2014-07-16
Paper
DOI: 10.1039/C4CP02146K
Exploring the phase space of time of flight mass selected PtxY nanoparticles
Federico Masini, Patricia Hernández-Fernández, Davide Deiana, Christian Ejersbo Strebel, David Norman McCarthy, Anders Bodin, Paolo Malacrida, Ifan Stephens, Ib Chorkendorff
2014-07-17
Paper
DOI: 10.1039/C4CP02144D
Exploring the complexity of quantum control optimization trajectories
Arun Nanduri, Ofer M. Shir, Ashley Donovan, Tak-San Ho, Herschel Rabitz
2014-11-07
Paper
DOI: 10.1039/C4CP03853C
Water and polymer dynamics in a model polysaccharide hydrogel: the role of hydrophobic/hydrophilic balance
V. Venuti, F. D'Amico, A. Gessini, F. Castiglione, C. Punta, L. Melone, V. Crupi, D. Majolino, F. Trotta, C. Masciovecchio
2014-11-11
Paper
DOI: 10.1039/C4CP04045G
Intra-residue interactions in proteins: interplay between serine or cysteine side chains and backbone conformations, revealed by laser spectroscopy of isolated model peptides
Himansu S. Biswal
2014-11-27
Paper
DOI: 10.1039/C4CP04449E
Intermediates caught in the act: tracing insulin amyloid fibril formation in time by combined optical spectroscopy, light scattering, mass spectrometry and microscopy
A. Gladytz, T. Häupl, K. R. Siefermann
2014-11-12
Paper
DOI: 10.1039/C4CP03072A
Mechanical properties and stabilities of α-boron monolayers
Qing Peng, Liang Han, Sheng Liu, Zhongfang Chen, Jie Lian, Suvranu De
2014-11-25
Paper
DOI: 10.1039/C4CP04050C
In situ non-aqueous nucleation and growth of next generation rare-earth-free permanent magnets
Aoran Xu, George E. Sterbinsky, Dario A. Arena, Ziying Wang, Peter W. Stephens
2014-11-21
Paper
DOI: 10.1039/C4CP04451G
You might also like
Compound Q&A
What is Ethyl 3-cyclohexylpropanoate (CAS: 10094-36-7)?
Ethyl 3-cyclohexylpropanoate is a clear, colorless to light yellow liquid with a...
10094-36-7Ethyl 3-cyclohexylpr...
Compound Q&A
How should waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl)nicotinic acid (CAS: 34783-31-8) be handled?
Waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl...
34783-31-82-(Hydroxymethyl)-5-...
Compound Q&A
How should waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) be handled?
Waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) sho...
858-46-82,4,6-Tris(pentafluo...
Compound Q&A
What precautions should be taken when handling Chloroac-nle-oh (CAS: 56787-36-1)?
When handling Chloroac-nle-oh (CAS: 56787-36-1), it is essential to wear appropr...
56787-36-1Chloroac-nle-oh
Compound Q&A
What industries use Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate (CAS: 752244-05-6)?
Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate is primarily used in the...
752244-05-6Ethyl 6-phenylimidaz...
Compound Q&A
Are there alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis?
Alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis ...
55095-15-3alpha-(2-Bromophenyl...
Compound Q&A
How should waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) be handled?
Waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) should be managed...
139585-48-12-Chloro-5-methoxypy...
Compound Q&A
What industries use 1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9)?
1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9) is used in various ...
5044-27-91-(4-Methoxyphenyl)-...
Compound Q&A
Are there alternatives to 3-Bromo-5-(N-Boc)aminomethylisoxazole (CAS: 903131-45-3) in synthesis?
There are alternative reagents and compounds that can be used in the synthesis o...
903131-45-33-Bromo-5-(N-Boc)ami...
Compound Q&A
What is Tungsten(IV) oxide (CAS: 12036-22-5)?
Tungsten(IV) oxide, also known as tungsten dioxide, is a chemical compound with ...
12036-22-5Tungsten(IV) oxide
Recommended Compounds
![2-{3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride (1:1) structure](https://static.chemtradehub.com/structs/253/25332-39-2-496e.webp "2-{3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride (1:1) structure")
2-{3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride (1:1)
CAS Number:
25332-39-2
Molecular Formula:
C19H23Cl2N5O
![Bis[(1,2,3,4,5-eta)-1-(diphenylphosphino)cyclopentadienyl]iron structure](https://static.chemtradehub.com/structs/121/12150-46-8-ecd2.webp "Bis[(1,2,3,4,5-eta)-1-(diphenylphosphino)cyclopentadienyl]iron structure")
Bis[(1,2,3,4,5-eta)-1-(diphenylphosphino)cyclopentadienyl]iron
CAS Number:
12150-46-8
Molecular Formula:
C34H28FeP2
Recommended Suppliers
Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.